Fennec Pharmaceuticals (FENC) Gross Profit (2023 - 2025)

Fennec Pharmaceuticals' Gross Profit history runs 3 years deep, the most recent figure standing at $12.0 million for Q4 2025.

• Quarterly Gross Profit rose 65.56% year-over-year to $12.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $40.9 million (down 7.84% YoY) and the FY2025 annual result came in at $40.9 million, down 7.84% from the prior year.
• Gross Profit was $12.0 million for Q4 2025 at Fennec Pharmaceuticals, up from $11.8 million in the prior quarter.
• Across five years, Gross Profit topped out at $24.8 million in Q1 2024 and bottomed at $1.6 million in Q1 2023.
• A 3-year average of $8.8 million and a median of $7.8 million in 2024 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2024 — Gross Profit surged 1469.34% — and 2025, when it sank 66.25%.
• Fennec Pharmaceuticals' Gross Profit stood at $9.0 million in 2023, then dropped by 19.82% to $7.3 million in 2024, then jumped by 65.56% to $12.0 million in 2025.
• Business Quant data shows FENC's Gross Profit at $12.0 million in Q4 2025, $11.8 million in Q3 2025, and $8.7 million in Q2 2025.